Chandrima Sanyal
·
July 26, 2025
Benzinga
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
read more
June 9, 2025
Bloomberg
June 10, 2025
June 13, 2025
Barchart